课题基金 / 基金详情

HISTONE H3 & H33 ARE DISPENSABLE FOR VIABILITY AND CLR4-DEPENDENT TRANSPOSITION

HISTONE H3 & H33 ARE DISPENSABLE FOR VIABILITY AND CLR4-DEPENDENT TRANSPOSITION
组蛋白H3
批准号:
7602160
负责人:
Hiten D Madhani
金额:
$0.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2008-08-31

项目摘要

项目成果

Hiten D Madhani的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Metazoan genomes and those of many plants and fungi encode genes for histone H3 and the variant H3.3, which differ at four amino acid positions. H3.3 has garnered much interest recently because, in contrast to H3, it displays deposition at active genes outside of S phase. It has therefore been proposed that it plays a specific role in the inheritance of epigenetic states, such as those mediated by specific histone modifications. However, to our knowledge, the effect of removing H3.3 from cells has not been reported. We therefore addressed its function by taking advantage of the fact that H3 and H3.3 are each encoded by a single locus in the genetically tractable basidiomycetous fungus, Cryptococcus neoformans. As part of this effort we are using affinity purification and MudPIT to characterize the soluble deposition complexes for H3 and H3.3. Our studies have revealed perfect conservation between C. neoformans and humans of the subunits of these deposition complexes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Manipulation of macrophage polarization by a fungal meningitis pathogen
Rapid production of SARS-CoV-2 molecular clones using CRISPR-based yeast recombineering
Epigenetic control of virulence in a fungal meningitis pathogen
Epigenetic control of virulence in a fungal meningitis pathogen
海外基金